Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 84,753 | 104,139 | 139,259 | 122,449 | 88,543 |
| Marketable Securities | 617,813 | 635,062 | 643,860 | 605,231 | 730,766 |
| Receivables | 2,251 | 1,778 | 2,206 | 5,592 | 4,302 |
| Inventories | 15,671 | 11,374 | 8,492 | 5,176 | 4,060 |
| TOTAL | $757,239 | $791,656 | $832,772 | $784,935 | $870,007 |
| Non-Current Assets | |||||
| PPE Net | 19,634 | 21,438 | 22,987 | 25,438 | 27,382 |
| Investments And Advances | 244,357 | 271,727 | 313,874 | 298,352 | 280,845 |
| Other Non-Current Assets | 63,923 | 66,477 | 69,085 | 71,595 | 74,233 |
| TOTAL | $327,914 | $359,642 | $405,946 | $395,385 | $382,460 |
| Total Assets | $1,085,153 | $1,151,298 | $1,238,718 | $1,180,320 | $1,252,467 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,626 | 8,662 | 18,616 | 10,415 | 7,790 |
| Accrued Expenses | 29,189 | 22,459 | 30,350 | 29,756 | 28,383 |
| TOTAL | $55,141 | $45,113 | $62,629 | $53,596 | $48,396 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 65,776 | 69,659 | 75,275 | 76,554 | 80,001 |
| TOTAL | $65,776 | $69,659 | $75,275 | $76,554 | $80,001 |
| Total Liabilities | $120,917 | $114,772 | $137,904 | $130,150 | $128,397 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 55,739 | 55,581 | 55,285 | 54,945 | 54,818 |
| Common Shares | 72 | 72 | 71 | 71 | 71 |
| Retained earnings | -635,385 | -551,579 | -470,561 | -507,087 | -425,340 |
| Other shareholders' equity | -9,356 | -8,897 | -13,021 | -15,569 | -10,988 |
| TOTAL | $964,236 | $1,036,526 | $1,100,814 | $1,050,170 | $1,124,070 |
| Total Liabilities And Equity | $1,085,153 | $1,151,298 | $1,238,718 | $1,180,320 | $1,252,467 |